As end-stage liver disease and hepatocarcinogenesis are associated with chronic intrahepatic and/or systemic inflammation, it is tempting to speculate that the pro-inflammatory effects of MIF, such as aggravating immune cell infiltration, might contribute to the increased incidence of complications such as decompensation or HCC development. Here, MIF is linked to hepatocellular carcinoma.